340B covered entities are exploring buying health insurance for patients at risk of contracting HIV in response to a huge reimbursement cut due to start in January for Gilead pre-exposure prophylaxis (PrEP) medications.
Blog Posts
SPONSORED CONTENT
The Net Promoter Score® (NPS) offers an objective measurement of what is arguably one of healthcare’s most critical—but subjective—areas of focus: patient satisfaction. It is a cross-industry standardized index designed to measure people’s willingness to recommend a company’s products or services to others. While traditional customer satisfaction surveys usually measure a customer’s perception of a specific interaction, NPS measures a customer’s overall attitude
…
Half of the Congressional Black Caucus (CBC) has asked Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure to end the nearly 30% cut in Medicare Part B drug payments to 340B hospitals.
Please Login
A federal appeals court is considering some South Carolina Walgreens customers’ claims that Walgreens, in its capacity as a 340B contract pharmacy and as a 340B contract pharmacy third-party administrator (TPA), violated their privacy rights under South Carolina law.
The final 340B covered entity registration period of the year began on Friday, Oct. 1 and ends on Friday, Oct. 15.
SPONSORED CONTENT
Running a 340B pharmacy is a complicated business, especially considering the varying requirements from payers that can wreak havoc on your bottom line. That’s why Sentry continually works to develop new tools and services to help you stay on top of things and keep your reimbursements moving.
Claims Manager Plus (CMP) is our solution; an automated software solution that helps
…
Q: Where did you grow up?
The Hawkeye State! The one and only Sioux City, Iowa.
Q: Where did you go to college/graduate school?
The University of Iowa for
…
A senior federal health official informed drug manufacturer Boehringer Ingelheim (BI) today its restrictions on 340B pricing when hospitals use contract pharmacies are illegal and must end immediately, or BI could face civil monetary penalties.
Please
The Biden administration this morning, as widely expected, announced it is rescinding the Trump administration’s regulatory requirement that community health centers pass along all their 340B savings on insulin and EpiPen-like devices to low-income patients with high-cost or no health
…
Pharmaceutical Research and Manufacturers of America (PhRMA) asked a federal district court yesterday to rule that Arkansas’s 340B nondiscrimination act does not require drug manufacturers “to offer price discounts under the 340B program to contract pharmacies in Arkansas.”
…
×
Sign up for news summaries and alerts from 340B Report